Keros Therapeutics Ownership & Insider Activity

Keros Therapeutics (KROS) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 4.6% of shares outstanding. Institutional investors hold 48.7%. Over the past 90 days, insiders made 1 purchase worth $10K and 4 sales worth $101K.

Shares Outstanding

19.792M

Shares Float

17.205M

Insider Shares Owned

917.331K

Insider % Owned

4.6%

Institutional Shares Held

9.657M

Institutional % Held

48.7%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$10K total

Sales (90d)

$101K total

Net Activity

Net Selling

Net Value (90d)

-$91K

Keros Therapeutics Insider Transactions (Last 6 Months)

すべてのインサイダー取引を見る →

Date	Insider	Title	Type	Shares	Price	Value
Aug 18, 2026	Annita Tanini	CORP. CONTROLLER & VP, FINANCE	SELL	1.224K	$10.29	$13K
Aug 18, 2026	Raquel Lorena Lerner	CHIEF SCIENTIFIC OFFICER	SELL	3.568K	$10.29	$37K
Aug 18, 2026	Esther Cho	CHIEF LEGAL OFFICER	SELL	4.485K	$10.29	$46K
Aug 18, 2026	Charles Newton	—	SELL	551.000	$10.30	$6K
Aug 17, 2026	JACQUES JEAN BIENAIME	—	BUY	1.000K	$10.27	$10K
Jul 15, 2026	JACQUES JEAN BIENAIME	—	BUY	1.000K	$10.61	$11K
Jun 15, 2026	JACQUES JEAN BIENAIME	—	BUY	1.000K	$10.19	$10K
Jun 11, 2026	Charles Newton	—	SELL	550.000	$10.04	$6K
Jun 4, 2026	Nima Farzan	—	SELL	2.625K	$10.73	$28K
Jun 4, 2026	Julius Knowles	—	SELL	2.625K	$10.73	$28K
Jun 4, 2026	Alpna Seth	—	SELL	2.625K	$10.72	$28K
May 15, 2026	JACQUES JEAN BIENAIME	—	BUY	1.000K	$10.58	$11K

More with Benzinga EdgeGet Access

Keros Therapeutics Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Keros Therapeutics Ownership & Insider Activity

Keros Therapeutics Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch